ENVB - Enveric Biosciences, Inc.
1.21
0 0%
Share volume: 24,477
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.21
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-15-2024 | 08-12-2024 | 11-14-2024 | 03-28-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 2.392 M | 1.813 M | 1.998 M | 3.091 M | |
| Selling general and admin | 1.934 M | 1.298 M | 1.236 M | 1.986 M | |
| Research and development | 458.155 K | 515.501 K | 762.717 K | 1.105 M | |
| Total expenses | 2.477 M | 1.898 M | 2.083 M | 3.174 M | |
| -23.39% | 9.76% | 52.35% | |||
| Operating income | -2.477 M | -1.898 M | -2.083 M | -3.174 M | |
| Ebit | -2.467 M | -1.887 M | -2.083 M | -3.150 M | |
| Pretax income | -2.455 M | -1.879 M | -2.084 M | -3.147 M | |
| -23.45% | 10.89% | 51.03% | |||
| Income tax | 1.731 K | 0.000 | 0.000 | 7.199 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.457 M | -1.879 M | -2.084 M | -3.155 M | |
| 23.51% | -10.89% | -51.37% |
